All Stories

  1. Computational Biology Dynamics of Mps1 Kinase Molecular Interactions with Isoflavones Reveals a Chemical Scaffold with Potential to Develop New Therapeutics for the Treatment of Cancer
  2. Identification of Novel Potential Heparanase Inhibitors Using Virtual Screening
  3. A Nanostructured Cu(II) Coordination Polymer Based on Alanine as a Trifunctional Mimic Enzyme and Efficient Composite in the Detection of Sphingobacteria
  4. Identification of New Dioxygenases Able to Recognize Polycyclic Aromatic Hydrocarbons with High Aromaticity
  5. Biodiversidad bacteriana presente en suelos contaminados con hidrocarburos para realizar biorremediación
  6. Novel SH-SAW Biosensors for Ultra-Fast Recognition of Growth Factors
  7. Preparation and Characterization of Aminoglycoside-Loaded Chitosan/Tripolyphosphate/Alginate Microspheres against E. coli
  8. De Novo Design of Selective Quadruplex–Duplex Junction Ligands and Structural Characterisation of Their Binding Mode: Targeting the G4 Hot‐Spot
  9. Front Cover: De Novo Design of Selective Quadruplex–Duplex Junction Ligands and Structural Characterisation of Their Binding Mode: Targeting the G4 Hot‐Spot (Chem. Eur. J. 20/2021)
  10. Deciphering Structural Determinants in Chondroitin Sulfate Binding to FGF-2: Paving the Way to Enhanced Predictability of Their Biological Functions
  11. Heparanized chitosans: towards the third generation of chitinous biomaterials
  12. Interfering with mRNA Methylation by the 2′O-Methyltransferase (NSP16) from SARS-CoV-2 to Tackle the COVID-19 Disease
  13. Biocatalysis: Chemical Biosynthesis
  14. Inhibition–Disruption of Candida glabrata Biofilms: Symmetrical Selenoesters as Potential Anti-Biofilm Agents
  15. Pseudokinases: From Allosteric Regulation of Catalytic Domains and the Formation of Macromolecular Assemblies to Emerging Drug Targets
  16. Synthesis of Ring II/III Fragment of Kanamycin: A New Minimum Structural Motif for Aminoglycoside Recognition
  17. Chondroitin Sulfate-Degrading Enzymes as Tools for the Development of New Pharmaceuticals
  18. A Molecular Modeling Approach to Identify Novel Inhibitors of the Major Facilitator Superfamily of Efflux Pump Transporters
  19. Theoretical Studies on Mechanism of Inactivation of Kanamycin A by 4′-O-Nucleotidyltransferase
  20. A holistic approach to unravelling chondroitin sulfation: Correlations between surface charge, structure and binding to growth factors
  21. Synthesis, physicochemical characterization and biological evaluation of chitosan sulfate as heparan sulfate mimics
  22. Biochemical profiling of rat embryonic stem cells grown on electrospun polyester fibers using synchrotron infrared microspectroscopy
  23. Overcoming Aminoglycoside Enzymatic Resistance: Design of Novel Antibiotics and Inhibitors
  24. Assembly of glycoamino acid building blocks: a new strategy for the straightforward synthesis of heparan sulfate mimics
  25. Highly improved enzymatic peptide synthesis by using biphasic reactors
  26. Microfluidic Reactors Based on Rechargeable Catalytic Porous Supports: Heterogeneous Enzymatic Catalysis via Reversible Host–Guest Interactions
  27. Finding the Right Candidate for the Right Position: A Fast NMR-Assisted Combinatorial Method for Optimizing Nucleic Acids Binders
  28. Selective modification of the 3′′-amino group of kanamycin prevents significant loss of activity in resistant bacterial strains
  29. 6-O-Nucleotidyltransferase: an aminoglycoside-modifying enzyme specific for streptomycin/streptidine
  30. Targeting RNA with Aminoglycosides: Current Improvements in their Synthesis and Biological Activity
  31. Modulating Weak Interactions for Molecular Recognition: A Dynamic Combinatorial Analysis for Assessing the Contribution of Electrostatics to the Stability of CH-π Bonds in Water
  32. A thorough experimental study of CH/π interactions in water: quantitative structure–stability relationships for carbohydrate/aromatic complexes
  33. Aryl Sulfotransferase fromHaliangium ochraceum: A Versatile Tool for the Sulfation of Small Molecules
  34. Chemical Interrogation of Drug/RNA Complexes: From Chemical Reactivity to Drug Design
  35. Multiple Keys for a Single Lock: The Unusual Structural Plasticity of the Nucleotidyltransferase (4′)/Kanamycin Complex
  36. Synthesis, biological assessment and molecular modeling of new multipotent MAO and cholinesterase inhibitors as potential drugs for the treatment of Alzheimer’s disease
  37. An Efficient and General Route to the Synthesis of Novel Aminoglycosides for RNA Binding
  38. Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles
  39. Role of Aromatic Rings in the Molecular Recognition of Aminoglycoside Antibiotics: Implications for Drug Design
  40. The Unusual Nucleotide Recognition Properties of the Resistance Enzyme ANT(4′): Inorganic Tri/Polyphosphate as a Substrate for Aminoglycoside Inactivation
  41. Structure-Based Design of Highly Crowded Ribostamycin/Kanamycin Hybrids as a New Family of Antibiotics
  42. Role of Conserved Salt Bridges in Homeodomain Stability and DNA Binding
  43. From Kinase to Cyclase: An Unusual Example of Catalytic Promiscuity Modulated by Metal Switching
  44. NMR-Based Analysis of Aminoglycoside Recognition by the Resistance Enzyme ANT(4′): The Pattern of OH/NH3+ Substitution Determines the Preferred Antibiotic Binding Mode and Is Critical for Drug Inactivation
  45. The Pattern of Distribution of Amino Groups Modulates the Structure and Dynamics of Natural Aminoglycosides:  Implications for RNA Recognition
  46. Rescue of the streptomycin antibiotic activity by using streptidine as a “decoy acceptor” for the aminoglycoside-inactivating enzyme adenyl transferase
  47. A simple NMR analysis of the protonation equilibrium that accompanies aminoglycoside recognition: Dramatic alterations in the neomycin-B protonation state upon binding to a 23-mer RNA aptamer
  48. Studies on the Conformational Features of Neomycin-B and its Molecular Recognition by RNA and Bacterial Defense Proteins
  49. Exploring the Use of Conformationally Locked Aminoglycosides as a New Strategy to Overcome Bacterial Resistance
  50. Molecular Recognition of Aminoglycoside Antibiotics by Bacterial Defence Proteins: NMR Study of the Structural and Conformational Features of Streptomycin Inactivation byBacillus subtilis Aminoglycoside-6-adenyl Transferase
  51. A Simple Structural-Based Approach to Prevent Aminoglycoside Inactivation by Bacterial Defense Proteins. Conformational Restriction Provides Effective Protection against Neomycin-B Nucleotidylation by ANT4
  52. Structure / Activity Relationship of Carba- and C-Fucopyranosides as Inhibitors of an α 1,6-Fucosyltransferase by Molecular Modeling and Kinetic Studies
  53. Synthesis, Inhibition Properties, and Theoretical Study of the New Nanomolar Trehalase Inhibitor 1-Thiatrehazolin: Towards a Structural Understanding of Trehazolin Inhibition
  54. Enzymes in the synthesis of bioactive compounds
  55. In Vivo Chaperone-Assisted Folding of α-1,6-Fucosyltransferase from Rhizobium sp.
  56. Synthesis of the aminocyclopentitol moieties of the hopanoids of Zymomonas mobilis and ‘Anacystis montana’
  57. Regioselective enzymatic hydrolysis of acetylated pyranoses and pyranosides using immobilised lipases. An easy chemoenzymatic synthesis of α- and β-d-glucopyranose acetates bearing a free secondary C-4 hydroxyl group
  58. C-Terminal truncation of α 1,6-fucosyltransferase from Rhizobium sp. does not annul the transferase activity of the enzyme
  59. Modulation of lipase properties in macro-aqueous systems by controlled enzyme immobilization: enantioselective hydrolysis of a chiral ester by immobilized Pseudomonas lipase
  60. Biocatalyst engineering exerts a dramatic effect on selectivity of hydrolysis catalyzed by immobilized lipases in aqueous medium
  61. Regioselective hydrolysis of peracetylated α-D-glucopyranose catalyzed by immobilized lipases in aqueous medium. A facile preparation of useful intermediates for oligosaccharide synthesis
  62. Reactivation strategies by unfolding/refolding of chymotrypsin derivatives after inactivation by organic solvents
  63. Syntheses of pharmaceutical oligosaccharides catalyzed by immobilized-stabilized derivatives of different β-galactosidases
  64. Preparation of activated supports containing low pK amino groups. A new tool for protein immobilization via the carboxyl coupling method
  65. Stabilization of Soluble Proteins by Intramolecular Crosslinking with Polyfunctional Macromolecules. Poly-(Glutaraldehyde-Like) Structure
  66. Enzyme Stabilization by Multipoint Covalent Attachment to Activated Pre-Existing Supports
  67. Fully Dispersed and Covalently Attached Chymotrypsin Derivatives as Industrial Catalysts in Biphasic Systems.
  68. Effect of immiscible organic solvents on activity/stability of native chymotrypsin and immobilized-stabilized derivatives
  69. Insolubilized Enzyme Derivatives in Organic Solvents: Mechanisms of Inactivation and Strategies for Reactivation
  70. Immobilization-stabilization of α-chymotrypsin by covalent attachment to aldehyde-agarose gels